InvestorsHub Logo

Aa5

Followers 0
Posts 50
Boards Moderated 0
Alias Born 04/13/2013

Aa5

Re: None

Thursday, 06/08/2023 12:11:06 PM

Thursday, June 08, 2023 12:11:06 PM

Post# of 2792
"One partial response showed nearly a 98.0% and 40.8% reduction in 2 tumor lesions for 17 months on study. "

I wish we had more information about the Phase 1 clinical trial. Share price dropping though.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NBIO News